White Paper

The Complexities of Ophthalmic Drug Development

Format: PDF file | Document type: White Paper | Promoted Content

This content is provided by Altasciences, and any views and opinions expressed do not necessarily reflect those of www.outsourcing-pharma.com

The Complexities of Ophthalmic Drug Development

Ophthalmic drug development comes with a unique set of challenges that can be mitigated by working with an end-to-end solution provider with regulatory knowledge and scientific expertise in this therapeutic area. Partnering with a single integrated CRO/CDMO can also save sponsors up to 40% in both time and costs.

In this issue of The Altascientist​, learn aboutkey considerations in each phase of ophthalmic drug development​―from prototype formulation through preclinical testing, to early phase clinical trials, and manufacturing(three case studies included)​.

Download your copy today!

Related resources from Altasciences

Show more

Supplier info centre